Drug interactions between famotidine and omeprazole
Pro Research Analysisby 
Searched over 200M research papers
Drug Interaction Overview: Famotidine and Omeprazole
Famotidine (an H2-receptor antagonist) and omeprazole (a proton pump inhibitor) are both commonly used to reduce stomach acid. Understanding their interactions is important for safe and effective treatment.
Safety and Adverse Effects: Famotidine vs. Omeprazole
Studies show that both famotidine and omeprazole have a low incidence of adverse drug reactions when used individually, with no significant effects on liver function or lipid profiles over a 12-week period . In clinical use for peptic ulcers, both drugs are generally well tolerated, with only mild and self-limiting side effects reported . In animal studies, both drugs also showed significant antiulcer effects, and combining them with other agents like amlodipine allowed for lower doses without loss of efficacy .
Pharmacokinetic Interactions with Other Drugs
Omeprazole, but not famotidine, can significantly increase blood levels of drugs metabolized by certain liver enzymes, such as tacrolimus, due to its inhibition of CYP2C19, CYP3A4, and CYP3A5. This means omeprazole can raise tacrolimus concentrations, while famotidine does not have this effect, making famotidine a safer choice for patients on tacrolimus . Similarly, omeprazole and other proton pump inhibitors can increase plasma methotrexate levels by inhibiting the OAT3 transporter, while famotidine does not significantly affect methotrexate elimination .
Combined Use: Famotidine and Omeprazole Together
Combining famotidine and omeprazole can provide faster and more sustained acid suppression than either drug alone. The combination raises gastric pH more quickly and maintains it above 4 for a longer period, especially in the first days of treatment. This is because famotidine acts quickly, while omeprazole has a longer-lasting effect . Clinical studies in patients with reflux esophagitis also show that the combination is more effective at relieving symptoms than either drug alone .
Cardiovascular and Gastrointestinal Considerations
Famotidine may reduce cardiac output and stroke volume in patients with heart failure, while omeprazole does not have these cardiovascular effects . In veterinary studies, both drugs increased gastrointestinal side effects when used with NSAIDs, but omeprazole was associated with more frequent and severe adverse events .
Mechanism of Action Differences
Omeprazole directly inhibits the (H+-K+) ATPase enzyme, the final step in acid secretion, while famotidine blocks histamine H2 receptors. Both are effective at reducing acid secretion, but omeprazole has a broader mechanism of action .
Conclusion
Famotidine and omeprazole do not have significant direct drug-drug interactions with each other and can be safely combined for enhanced acid suppression. However, omeprazole can interact with other medications by affecting their metabolism, while famotidine does not. The combination of both drugs can provide rapid and sustained acid control, but individual patient factors and potential interactions with other medications should always be considered.
Sources and full results
Most relevant research papers on this topic